Aldeyra Therapeutics Announces Board and Executive Changes
Ticker: ALDX · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1341235
| Field | Detail |
|---|---|
| Company | Aldeyra Therapeutics, INC. (ALDX) |
| Form Type | 8-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: ALDX
TL;DR
Aldeyra shakes up board and exec pay on 4/17.
AI Summary
Aldeyra Therapeutics, Inc. announced on April 17, 2025, changes related to its board of directors and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial priorities.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategic direction and operational stability.
Key Players & Entities
- Aldeyra Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- April 17, 2025 (date) — Date of earliest event reported
FAQ
What specific roles have been affected by the departures of officers or directors?
The filing indicates "Departure of Directors or Certain Officers" as an item, but does not specify the exact roles in the provided text.
Who are the newly elected directors?
The filing lists "Election of Directors" as an item, but the names of the newly elected directors are not provided in the text.
What are the details of the compensatory arrangements for certain officers?
The filing mentions "Compensatory Arrangements of Certain Officers" but does not provide specific details on these arrangements in the text.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated April 17, 2025.
What is Aldeyra Therapeutics, Inc.'s SIC code?
Aldeyra Therapeutics, Inc.'s Standard Industrial Classification (SIC) code is 2834, Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding Aldeyra Therapeutics, Inc. (ALDX).